E-MAIL: [email protected]
The FDA continues to support the critical work of drug take back programs. We continue to work with manufacturers to develop new formulations with reduced risk for accidental harm and with our fe...
272021.04
The following human products intended for oral administration: aspirin; prescription drugs and controlled drugs; products contain...
The U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined that the...
262021.04
The U.S. Food and Drug Administration approved Opdivo (nivolumab), in combination with certain types of chemotherapy, for t...
Copyright © Shijiazhuang Xinfuda Medical Packaging Co., Ltd. All Rights
Reserved Powered by
MAKE AN ENQUIRY
